Compare TNON & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNON | AQB |
|---|---|---|
| Founded | 2012 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 3.9M |
| IPO Year | 2022 | N/A |
| Metric | TNON | AQB |
|---|---|---|
| Price | $1.14 | $0.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 103.3K | 32.3K |
| Earning Date | 11-13-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,233,000.00 | N/A |
| Revenue This Year | $19.56 | N/A |
| Revenue Next Year | $71.06 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.85 | $0.47 |
| 52 Week High | $5.85 | $2.95 |
| Indicator | TNON | AQB |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 37.46 |
| Support Level | $1.11 | $0.91 |
| Resistance Level | $1.15 | $1.03 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 81.82 | 28.11 |
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.